Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Recent evidence supports a role for glutamate receptors in the pathophysiology of multiple sclerosis. In the present study, we have focused specifically on the expression of metabotropic glutamate receptors (mGluRs) in multiple sclerosis brain tissue. The expression of group I (mGluR1alpha and mGluR5) and group II (mGluR2/3) mGluRs was studied using immunohistochemistry in tissue from 12 multiple sclerosis cases and seven non-neurological controls. The expression patterns of both group I and II mGluRs in multiple sclerosis tissue differed significantly from those in control tissue. Strong mGluR1alpha immunoreactivity was observed in axons of the subcortical white matter, particularly in the centre of actively demyelinating lesions and in the borders of chronic active lesions. mGluR1alpha axonal immunopositivity was also found in normal appearing multiple sclerosis white matter, but axons in control white matter were generally negative. mGluR1alpha axonal labelling was associated with the presence of non-phosphorylated neurofilaments and beta-amyloid precursor protein, which are sensitive markers for axonal injury and disturbed axonal transport. Changes in mGluR immunoreactivity were also observed in glia. A diffuse increase in the expression of mGluR5 and mGluR2/3 was detected in reactive astrocytes in multiple sclerosis lesions. However, only a subpopulation of reactive astroglial cells expressed mGluR1alpha. In addition, labelling with antibodies to mGluR2/3 and, to a lesser extent labelling with antibodies to mGluR1alpha, was detected in a population of cells of the microglial/macrophage lineage that displayed a macrophage-like morphology. Our data suggest that mGluRs, like ionotropic glutamate receptors, play a role in the complex processes that are associated with the progressive brain damage in multiple sclerosis, including both glial activation and pathological changes in axons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
The metabotropic glutamate receptors: Structure and functions
Pin, J.-P., & Duvoisin, R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00129-g · Cited by 2,266 · cited 2×
“mGluRs consist of at least eight subtypes and they regulate a variety of intracellular signalling systems via activation of GTP-binding proteins (Pin and Duvoisin, 1995; Schoepp et al., 1999).”
BackgroundAxonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532 · cited 7×
“…phases of the disease (Ferguson et al., 1997; Trapp et al., 1998; Bitsch et al., 2000, 2001) and have been correlated with disease progression (Ferguson et al., 1997; Kalkers et al., 2001; Wujek et al., 2002) and cognitive decline (Comi et al., 1993; Leocani and Comi, 2000; Edwards et al.,…”
BackgroundInfluentialPharmacological agents acting at subtypes of metabotropic glutamate receptors
Schoepp, D. D., Jane, D. E., & Monn, J. A. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00092-1 · Cited by 1,060 · cited 3×
“Group I includes mGluR1 and -5, which are coupled to phosphoinositide hydrolysis, while group II (mGluR2 and -3) and group III (mGluR4, -6, -7 and -8) mGluRs are negatively coupled to adenylyl cyclase (Schoepp et al., 1999).”
BackgroundBaude, A., Nusser, Z., Roberts, J. D. B., Mulvihill, E., Jeffrey Mcllhinney, R. A., & Somogyi, P. (1993) · Neuron · doi:10.1016/0896-6273(93)90086-7 · Cited by 927
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 3×
“Double-labelling of sections with Abs to mGluR1a and b-APP (a molecule enriched in axons with a disturbance in axonal transport; Ferguson et al., 1997; Kornek et al., 2000; Bitsch et al., 2000; Kuhlmann et al., 2002) showed colocalization in some axons (Fig.”
BackgroundRegulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883 · cited 3×
“…bright®eld and dark-®eld optics, epi-UV illumination and selective ®lters optimized for distinguishing between FITC, Cy3 and Cy5 emission, or on a Zeiss 410 inverted confocal laser scanning microscope equipped with lasers emitting at 488, 543 and 633 nm to excite FITC, Cy3 and Cy5, respectively.”
BackgroundKuhlmann, T. (2002) · Brain · doi:10.1093/brain/awf235 · Cited by 775 · cited 2×
“Double-labelling of sections with Abs to mGluR1a and b-APP (a molecule enriched in axons with a disturbance in axonal transport; Ferguson et al., 1997; Kornek et al., 2000; Bitsch et al., 2000; Kuhlmann et al., 2002) showed colocalization in some axons (Fig.”
BackgroundGlutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744 · cited 2×
“…role of ionotropic glutamate receptors, which are ligand-gated ion channels [including N-methyl-D-aspartate (NMDA), kainate and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors] in the pathogenesis of multiple sclerosis (Matute, 1998; Pitt et al., 2000; Paul and Bolton, 2002).”
Background
Cited by
Metabotropic glutamate receptors: From the workbench to the bedside
Nicoletti, F., Bockaert, J., Collingridge, G. L., Conn, P. J., Ferraguti, F., Schoepp, D. D., Wroblewski, J. T., & Pin, J. P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.022 · Cited by 653
Grey matter pathology in multiple sclerosis
Geurts, J. J., & Barkhof, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70191-1 · Cited by 507
Self-citationMechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Dutta, R., & Trapp, B. D. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.005 · Cited by 457
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Dutta, R., & Trapp, B. D. (2007) · Neurology · doi:10.1212/01.wnl.0000275229.13012.32 · Cited by 412
Centonze, D., Muzio, L., Rossi, S., Cavasinni, F., De Chiara, V., Bergami, A., Musella, A., D'Amelio, M., Cavallucci, V., Martorana, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5804-08.2009 · Cited by 390
“Furthermore, glutamate clearance and receptor expression are impaired in MS brains (Pitt et al., 2000; Geurts et al., 2003, 2005; VallejoIllarramendi et al., 2006) and in animal models of the disease (Hardin-Pouzet et al., 1997; Pitt et al., 2000; Smith et al., 2000; Ohgoh et al., 2002), whereas…”
BackgroundMicroglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra
Kaushal, V., & Schlichter, L. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5643-07.2008 · Cited by 346
Glutamate‐mediated glial injury: Mechanisms and clinical importance
Matute, C., Domercq, M., & Sánchez‐Gómez, M. (2006) · Glia · doi:10.1002/glia.20275 · Cited by 330
Extensive Hippocampal Demyelination in Multiple Sclerosis
Geurts, J. J. G., Bö, L., Roosendaal, S. D., Hazes, T., Daniëls, R., Barkhof, F., Witter, M. P., Huitinga, I., & van der Valk, P. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181461f54 · Cited by 287
Self-citationSynaptopathy connects inflammation and neurodegeneration in multiple sclerosis
Mandolesi, G., Gentile, A., Musella, A., Fresegna, D., De Vito, F., Bullitta, S., Sepman, H., Marfia, G. A., & Centonze, D. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.222 · Cited by 286
The IL-1β system in epilepsy-associated malformations of cortical development
Ravizza, T., Boer, K., Redeker, S., Spliet, W. G. M., van Rijen, P. C., Troost, D., Vezzani, A., & Aronica, E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.003 · Cited by 268
Self-citationNetwork Collapse and Cognitive Impairment in Multiple Sclerosis
Schoonheim, M. M., Meijer, K. A., & Geurts, J. J. G. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00082 · Cited by 233
“Such intervention studies aiming to increase neurotransmitter levels in MS appear logical, as there is an apparent cholinergic (45) as well as glutamate (46) imbalance in MS, which might leave the network unstable.”
BackgroundSelf-citationByrnes, K. R., Stoica, B., Loane, D. J., Riccio, A., Davis, M. I., & Faden, A. I. (2009) · Glia · doi:10.1002/glia.20783 · Cited by 183
“Previous studies have reported the presence of mGluRs on immune cells such as microglia, macrophages, and lymphocytes (Geurts et al., 2003; Pacheco et al., 2004; Rezzani et al., 2003; Taylor et al., 2005).”
Synaptic pathology: A shared mechanism in neurological disease
Henstridge, C. M., Pickett, E., & Spires-Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 174
“Also, increased expression of glutamate receptors in glial cells and ectopic expression in axons is observed around active MS lesions [163, 164].”
Cognitive impairment and cortical degeneration in neuromyelitis optica
Saji, E., Arakawa, M., Yanagawa, K., Toyoshima, Y., Yokoseki, A., Okamoto, K., Otsuki, M., Akazawa, K., Kakita, A., Takahashi, H., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23721 · Cited by 174
Evidence of activated microglia in focal cortical dysplasia
Boer, K., Spliet, W. G. M., van Rijen, P. C., Redeker, S., Troost, D., & Aronica, E. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.002 · Cited by 168
Self-citationGlutamate Receptor Expression in Multiple Sclerosis Lesions
Newcombe, J., Uddin, A., Dove, R., Patel, B., Turski, L., Nishizawa, Y., & Smith, T. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00101.x · Cited by 164
Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
Spampinato, S. F., Copani, A., Nicoletti, F., Sortino, M. A., & Caraci, F. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00414 · Cited by 105
“Glutamatergic system plays a key role in the pathophysiology of chronic pain and in particular in central sensitization (Guida et al., 2015; Hossain et al., 2017) and neurodegenerative processes leading to cognitive deficits (Giordano et al., 2012).”
BackgroundIn vivo evidence of glutamate toxicity in multiple sclerosis
Azevedo, C. J., Kornak, J., Chu, P., Sampat, M., Okuda, D. T., Cree, B. A., Nelson, S. J., Hauser, S. L., & Pelletier, D. (2014) · Annals of Neurology · doi:10.1002/ana.24202 · Cited by 100
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain
Azami Tameh, A., Clarner, T., Beyer, C., Atlasi, M. A., Hassanzadeh, G., & Naderian, H. (2013) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2013.03.004 · Cited by 43
“reported no obvious changes in the expression of mGluR2/3 receptor subtypes in the cortical gray matter of MS patients (Geurts et al., 2003).”
Background
Metadata
- Authors
- Geurts, J. J. G.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-04
- Volume
- 126
- Issue
- 8
- Pages
- 1755-1766
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2144508667
- Cited by
- 194
- References
- 88
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.